VSGNE/NESVS Vascular Research Fellowship (2025-2026)
The VSGNE/NESVS Vascular Research Fellowship will run for 12 months (July 2025 – June 2026). The course will consist of 12 lectures which will take place virtually on a monthly basis. Additionally, residents and medical students will be paired with a research mentor who will help them complete a vascular research project.
The project should focus on using VQI data and the mentor will provide assistance on project design, submitting a proposal to the regional RAC, statistical analysis, submission of an abstract to either VAM or the VSGNE regional meeting and writing of the paper. The first half of the year will focus on how to complete a VQI project, while the second half of the year will provide education on other types of research projects. Participants will also be invited to attend a Research Advisory Committee (RAC) meeting and take part in the twice-yearly VSGNE meeting.
Awards
After completion of the course, projects will be evaluated and the top project will be featured at the spring 2026 VSGNE meeting. For all participants in the course, cost of attending the 2026 NESVS Annual Meeting (in Stowe, VT) will be waived. Thanks to a grant from Terumo, each participant will receive a $750 scholarship to offset travel and housing costs of the 2026 NESVS Annual Meeting and the registration fee will be waived.
Application Requirements
- Applicant must be enrolled in an accredited Osteopathic or Allopathic medical school or enrolled in a General or Vascular Surgery residency program in New England. Medical Students and Residents who are not enrolled in New England programs, but who are members of NESVS, are also eligible.
- Applicant must submit a CV, as well as an essay no more than 500 words describing their interest in vascular research, their anticipated career trajectory and their general research area of interest.
- If the applicant has a faculty mentor we will work with them, but faculty mentorship is not required.
- Applications are due by Monday, June 2, 2025.